Hans-Ullrich Völker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hans-Ullrich Völker has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Matthias Scheich
Department of Otorhinolaryngology, University Würzburg, Germany
3 shared publications- Matthias Scheich
Dept. of Otorhinolaryngology, University of Würzburg, Germany
3 shared publications Rudolf Hagen
Department of Otorhinolaryngology, University Würzburg, Germany
3 shared publications- Alexandra Metzger
Institute of Pathology, University of Würzburg, Germany
2 shared publications Andreas Zettl
Institute of Pathology, University Würzburg, Germany
2 shared publications- Imme Haubitz
Department of General, Visceral, Transplantation, Vascular and Paediatric Surgery, University Hospital Würzburg, 97080 Würzburg, Germany
2 shared publications
Latest Publications
- 1 May 2016
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 77 (S 02) , LFP-08-07
Lesions Mimicking Small Acoustic Neuromas
Objective: Most tumors of the internal auditory canal are acoustic neuromas (AN). Preoperative diagnosis is based on typical clinical symptoms and radiological findings in MR imaging. In rare cases histopathology shows up with different results. Methods: Retrospective chart and histology review of 207 cases of AN surgery via middle cranial fossa (MCF) approach that have been performed between 12/2005 and 01/2015. 166 histologies were analyzed. Results: Histopathology revealed three meningiomas and two cases of lipoma/lipomatous hamartoma. Clinical presentation was typical for AN in all five cases (i.e., hearing loss, vertigo, tinnitus). In preoperative MR imaging all tumors were suspected to be an AN by a neuroradiologist. Retrospective analysis of the preoperative imaging did not lead to modification of the diagnosis. Intraoperative findings (according to the surgeons’ report) showed increased scarifications in two cases. Conclusion: Cerebellopontine angle lesions other than acoustic neuroma are unusual but have to be taken into account. In very small tumors imaging still remains difficult. This should also be considered in cases of radiotherapy without proof of histology.
- 1 May 2016
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 77 (S 02) , LFP-08-07
Lesions Mimicking Small Acoustic Neuromas
Objective: Most tumors of the internal auditory canal are acoustic neuromas (AN). Preoperative diagnosis is based on typical clinical symptoms and radiological findings in MR imaging. In rare cases histopathology shows up with different results. Methods: Retrospective chart and histology review of 207 cases of AN surgery via middle cranial fossa (MCF) approach that have been performed between 12/2005 and 01/2015. 166 histologies were analyzed. Results: Histopathology revealed three meningiomas and two cases of lipoma/lipomatous hamartoma. Clinical presentation was typical for AN in all five cases (i.e., hearing loss, vertigo, tinnitus). In preoperative MR imaging all tumors were suspected to be an AN by a neuroradiologist. Retrospective analysis of the preoperative imaging did not lead to modification of the diagnosis. Intraoperative findings (according to the surgeons’ report) showed increased scarifications in two cases. Conclusion: Cerebellopontine angle lesions other than acoustic neuroma are unusual but have to be taken into account. In very small tumors imaging still remains difficult. This should also be considered in cases of radiotherapy without proof of histology.
- 8 April 2010
- Published by Wiley in Head & Neck
- Vol. 32 (5) , 679-683
Leiomyosarcoma of the larynx as a local relapse of squamous cell carcinoma—Report of an unusual case
Background. The authors report on leiomyosarcoma after previously treated squamous cell carcinoma (SCC) at the glottis. Methods. Primary tumor and relapses were investigated morphologically, immunohistochemically, and with molecular methods. Results. The SCC was typical, but few cells showed a spindle‐shaped pattern. The relapse tumor was a spindle‐shaped and epitheloid tumor with the morphological and immunohistochemical appearance of leiomyosarcoma (sm‐actin+, desmin+, caldesmon+, vimentin+, keratin−). The comparative genomic hybridization (CGH) revealed some gains and losses in the leiomyosarcoma. Because of altered material, the investigation failed in the primary. A fluorescence in situ hybridization (5p) focally detected 3 chromosmomal copies, corresponding to gains on 5p in CGH of leiomyosarcoma. Conclusion. Leiomyosarcoma after SCC is very uncommon. A connection between both seems likely in this case. Transdifferentiation, also seen in other tumors or carcinosarcomas, could be based on aberrant differentiation of a pluripotent stem cell. © 2009 Wiley Periodicals, Inc. Head Neck, 2010
- 8 April 2010
- Published by Wiley in Head & Neck
- Vol. 32 (5) , 679-683
Leiomyosarcoma of the larynx as a local relapse of squamous cell carcinoma—Report of an unusual case
Background. The authors report on leiomyosarcoma after previously treated squamous cell carcinoma (SCC) at the glottis. Methods. Primary tumor and relapses were investigated morphologically, immunohistochemically, and with molecular methods. Results. The SCC was typical, but few cells showed a spindle‐shaped pattern. The relapse tumor was a spindle‐shaped and epitheloid tumor with the morphological and immunohistochemical appearance of leiomyosarcoma (sm‐actin+, desmin+, caldesmon+, vimentin+, keratin−). The comparative genomic hybridization (CGH) revealed some gains and losses in the leiomyosarcoma. Because of altered material, the investigation failed in the primary. A fluorescence in situ hybridization (5p) focally detected 3 chromosmomal copies, corresponding to gains on 5p in CGH of leiomyosarcoma. Conclusion. Leiomyosarcoma after SCC is very uncommon. A connection between both seems likely in this case. Transdifferentiation, also seen in other tumors or carcinosarcomas, could be based on aberrant differentiation of a pluripotent stem cell. © 2009 Wiley Periodicals, Inc. Head Neck, 2010
- 29 September 2009
- Published by Wiley in Head & Neck
- Vol. 32 (11) , 1573-1578
Laryngeal inflammatory myofibroblastic tumors: Different clinical appearance and histomorphologic presentation of one entity
Background: Inflammatory myofibroblastic tumors (IMFTs) of the larynx are rare. We report the clinical presentation, histomorphology, and new molecular findings of 2 cases.Methods: Paraffin‐embedded specimens were stained immunohistochemically (eg, vimentin, AE1/3, Alk‐1, smooth muscle [sm‐]actin, p53, Rb1, immunoglobulin G4 [IgG4]). Epstein–Barr virus–encoded RNA (EBER) in situ hybridization and HHV8–polymerase chain reaction (PCR) were done. Comparative genomic hybridization (CGH) was performed.Results: Case 1 was that of a 56‐year‐old man with an infiltrating plasma‐cell–rich tumor (Alk‐1‐, sm‐actin+). Plasma cells were strongly positive for IgG4. CGH was unsuspicious. Case 2 was that of a 34‐year‐old woman with an exophytic tumor (Alk‐1+). CGH revealed losses on 13q14–22. The few plasma cells were negative for IgG4. The proliferation (Ki67) was low in both cases.Conclusion: Different types of IMFTs may exist and could indicate different therapeutic strategies. Alk‐1‐positive cases with only scattered inflammatory cells could represent the neoplastic variant, whereas cases rich in plasma cells could be associated with IgG4 sclerosing diseases. © 2009 Wiley Periodicals, Inc. Head Neck, 2009
- 29 September 2009
- Published by Wiley in Head & Neck
- Vol. 32 (11) , 1573-1578
Laryngeal inflammatory myofibroblastic tumors: Different clinical appearance and histomorphologic presentation of one entity
Background: Inflammatory myofibroblastic tumors (IMFTs) of the larynx are rare. We report the clinical presentation, histomorphology, and new molecular findings of 2 cases.Methods: Paraffin‐embedded specimens were stained immunohistochemically (eg, vimentin, AE1/3, Alk‐1, smooth muscle [sm‐]actin, p53, Rb1, immunoglobulin G4 [IgG4]). Epstein–Barr virus–encoded RNA (EBER) in situ hybridization and HHV8–polymerase chain reaction (PCR) were done. Comparative genomic hybridization (CGH) was performed.Results: Case 1 was that of a 56‐year‐old man with an infiltrating plasma‐cell–rich tumor (Alk‐1‐, sm‐actin+). Plasma cells were strongly positive for IgG4. CGH was unsuspicious. Case 2 was that of a 34‐year‐old woman with an exophytic tumor (Alk‐1+). CGH revealed losses on 13q14–22. The few plasma cells were negative for IgG4. The proliferation (Ki67) was low in both cases.Conclusion: Different types of IMFTs may exist and could indicate different therapeutic strategies. Alk‐1‐positive cases with only scattered inflammatory cells could represent the neoplastic variant, whereas cases rich in plasma cells could be associated with IgG4 sclerosing diseases. © 2009 Wiley Periodicals, Inc. Head Neck, 2009
- 9 September 2009
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 107 (3) , 251-252
Idiopathic intrauterine myocardial infarction without malformations of the heart or coronary vessels as a cause of stillbirth
- 9 September 2009
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 107 (3) , 251-252
Idiopathic intrauterine myocardial infarction without malformations of the heart or coronary vessels as a cause of stillbirth
- Open Access
- 4 March 2009
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 7 (1) , 25
Lymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx – value of conventional evaluation and additional immunohistochemical staining of D2-40
Recent studies revealed a predictive value of lymphatic vessel invasion (L1) for the nodal metastasizing and poor prognosis in malignant tumors at different sites. The monoclonal antibody D2-40 (podoplanin) stains specifically endothelial cells of lymphatic vessels and improves the search for L1. However, the importance of this immunohistochemical staining was not investigated in squamous cell carcinomas (SCC) of larynx and hypopharynx.
- 4 March 2009
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 7 (1) , 25
Open AccessLymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx – value of conventional evaluation and additional immunohistochemical staining of D2-40
Recent studies revealed a predictive value of lymphatic vessel invasion (L1) for the nodal metastasizing and poor prognosis in malignant tumors at different sites. The monoclonal antibody D2-40 (podoplanin) stains specifically endothelial cells of lymphatic vessels and improves the search for L1. However, the importance of this immunohistochemical staining was not investigated in squamous cell carcinomas (SCC) of larynx and hypopharynx.
- Open Access
- 1 January 2009
- Published by Springer Nature in Diagnostic Pathology
- Vol. 4 (1) , 18
Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses
Adenoid cystic carcinomas are rare tumors with an indolent clinical course, but frequent local relapses. The identification of tumors with a higher relapse risk seems to be interesting. Hence we investigated parameters of glucose metabolism, which were found associated with poor prognosis in other malignancies.
- 1 January 2009
- Published by Springer Nature in Diagnostic Pathology
- Vol. 4 (1) , 18
Open AccessExpression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses
Adenoid cystic carcinomas are rare tumors with an indolent clinical course, but frequent local relapses. The identification of tumors with a higher relapse risk seems to be interesting. Hence we investigated parameters of glucose metabolism, which were found associated with poor prognosis in other malignancies.
- 8 December 2008
- Published by Georg Thieme Verlag KG in Laryngo-Rhino-Otologie
- Vol. 88 (03) , 186-190
Mittelohradenom/Mittelohrkarzinoid – ein unproblematischer Tumor?
Hintergrund: Mittelohradenome/Mittelohrkar-zinoide sind sehr seltene Tumoren meist jüngerer Patienten. Dabei sind die Begriffe Mittelohradenom und -karzinoid synonym zu betrachten, wobei die WHO den Begriff Mittelohradenom (MOA) favorisiert. Sie manifestieren sich mit uncharakteristischen Symptomen oft nach längerem klinischen Verlauf. Da die Tumore meist nicht metastasieren, gelten sie als benigne. Nach Literaturangaben gilt der klinische Verlauf in der Regel als unkompliziert und die chirurgische Therapie als ausreichend. Methode und Patienten: Die Arbeit berichtet über den klinischen Verlauf und die diagnostischen Probleme von vier Tumoren. Ergebnisse: Die Patienten (2 männlich, 2 weiblich, 25–38 Jahre) zeigten ein vergleichbares Krank-heitsbild mit Hörminderung, Ohrgeräuschen und teils Schmerzen. Nach primärer Operation waren im Gegensatz zu den nach der Literatur zu erwartenden Verläufen bis zu 10 Operationen nötig. In einem Fall kam es zu einem, in einem weiteren zu sechs Rezidiven. Hier wurde adjuvant radiotherapiert. Die histologische Differenzialdiagnose bereitete in einem Fall Schwierigkeiten. In diesem gelang es bei atypischer Morphologie nicht, den Tumor im intraoperativen Schnellschnitt sicher zu klassifizieren. Schlussfolgerungen: MOA zeigen einen weit komplizierteren Verlauf als nach Literaturdaten zu erwarten wäre. Verantwortlich ist vor allem die Schwierigkeit, eine vollständige chirurgische Entfernung zu erreichen. Es sollte daher schon in der Planung ein chirurgisch umfassendes Therapieregime mit engmaschigen Nachkontrollen gewählt werden. Im komplizierten Einzelfall kann eine adjuvante Bestrahlung hilfreich sein. Middle Ear Adenoma/Middle Ear Carcinoid – An Unproblematic Tumor? Objectives: Adenomas/carcinoid tumors of the middle ear are very rare tumors of young to middle aged patients. The terms adenoma and carcinoid tumor of the middle ear can be used as synonyms, with the WHO favouring the term middle ear adenoma (MEA). These tumors usually present with unspecific clinical symptoms and a long case history. They are classified as benign tumors with only very few reported cases of regional metastasis after years of disease. According to recent literature, the clinical course is usually uncomplicated with complete surgical excision being adequate therapy. Methods and patients: This study describes the clinical course and the diagnostic challenges in four cases of this rare tumor entity. Results: The selected patients (2 males, 2 females, 25–38 years old) showed very similar clinical findings with decreased hearing acuity, tinnitus and sometimes pain. After the primary surgical excision up to 10 further operations were necessary, this being in contrast to the usual clinical course as described in the literature. In two cases a tumor recurrence was documented with one case recurring six times. In this case adjuvant radiotherapy (70 Gy) was performed. The histological differential diagnosis can also be problematic; in one case with a highly atypical morphology it was impossible to arrive at a definite diagnosis during the analysis of a frozen section. Conclusion: Adenomas of the middle ear can have a much more complicated clinical course than is suggested by the recent literature. The presented cases in this study and the analysis of previously published cases shows that the typical progression described by the current WHO-classification with unproblematic surgical management of the tumor and an uncomplicated further clinical course does not always correspond to reality. The main reason for this is the difficulty in obtaining a complete surgical excision. Therefore, a well-planned and comprehensive surgical management with a high frequency of follow-up examinations should be chosen. In complicated individual cases adjuvant radiotherapy can be helpful.
- 8 December 2008
- Published by Georg Thieme Verlag KG in Laryngo-Rhino-Otologie
- Vol. 88 (03) , 186-190
Mittelohradenom/Mittelohrkarzinoid – ein unproblematischer Tumor?
Hintergrund: Mittelohradenome/Mittelohrkar-zinoide sind sehr seltene Tumoren meist jüngerer Patienten. Dabei sind die Begriffe Mittelohradenom und -karzinoid synonym zu betrachten, wobei die WHO den Begriff Mittelohradenom (MOA) favorisiert. Sie manifestieren sich mit uncharakteristischen Symptomen oft nach längerem klinischen Verlauf. Da die Tumore meist nicht metastasieren, gelten sie als benigne. Nach Literaturangaben gilt der klinische Verlauf in der Regel als unkompliziert und die chirurgische Therapie als ausreichend. Methode und Patienten: Die Arbeit berichtet über den klinischen Verlauf und die diagnostischen Probleme von vier Tumoren. Ergebnisse: Die Patienten (2 männlich, 2 weiblich, 25–38 Jahre) zeigten ein vergleichbares Krank-heitsbild mit Hörminderung, Ohrgeräuschen und teils Schmerzen. Nach primärer Operation waren im Gegensatz zu den nach der Literatur zu erwartenden Verläufen bis zu 10 Operationen nötig. In einem Fall kam es zu einem, in einem weiteren zu sechs Rezidiven. Hier wurde adjuvant radiotherapiert. Die histologische Differenzialdiagnose bereitete in einem Fall Schwierigkeiten. In diesem gelang es bei atypischer Morphologie nicht, den Tumor im intraoperativen Schnellschnitt sicher zu klassifizieren. Schlussfolgerungen: MOA zeigen einen weit komplizierteren Verlauf als nach Literaturdaten zu erwarten wäre. Verantwortlich ist vor allem die Schwierigkeit, eine vollständige chirurgische Entfernung zu erreichen. Es sollte daher schon in der Planung ein chirurgisch umfassendes Therapieregime mit engmaschigen Nachkontrollen gewählt werden. Im komplizierten Einzelfall kann eine adjuvante Bestrahlung hilfreich sein. Middle Ear Adenoma/Middle Ear Carcinoid – An Unproblematic Tumor? Objectives: Adenomas/carcinoid tumors of the middle ear are very rare tumors of young to middle aged patients. The terms adenoma and carcinoid tumor of the middle ear can be used as synonyms, with the WHO favouring the term middle ear adenoma (MEA). These tumors usually present with unspecific clinical symptoms and a long case history. They are classified as benign tumors with only very few reported cases of regional metastasis after years of disease. According to recent literature, the clinical course is usually uncomplicated with complete surgical excision being adequate therapy. Methods and patients: This study describes the clinical course and the diagnostic challenges in four cases of this rare tumor entity. Results: The selected patients (2 males, 2 females, 25–38 years old) showed very similar clinical findings with decreased hearing acuity, tinnitus and sometimes pain. After the primary surgical excision up to 10 further operations were necessary, this being in contrast to the usual clinical course as described in the literature. In two cases a tumor recurrence was documented with one case recurring six times. In this case adjuvant radiotherapy (70 Gy) was performed. The histological differential diagnosis can also be problematic; in one case with a highly atypical morphology it was impossible to arrive at a definite diagnosis during the analysis of a frozen section. Conclusion: Adenomas of the middle ear can have a much more complicated clinical course than is suggested by the recent literature. The presented cases in this study and the analysis of previously published cases shows that the typical progression described by the current WHO-classification with unproblematic surgical management of the tumor and an uncomplicated further clinical course does not always correspond to reality. The main reason for this is the difficulty in obtaining a complete surgical excision. Therefore, a well-planned and comprehensive surgical management with a high frequency of follow-up examinations should be chosen. In complicated individual cases adjuvant radiotherapy can be helpful.
- 30 September 2007
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 109 (7) , 624-630
Progressive multifocal leukoencephalopathy developing in advanced pulmonal sarcoidosis
- 30 September 2007
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 109 (7) , 624-630
Progressive multifocal leukoencephalopathy developing in advanced pulmonal sarcoidosis
- 23 August 2007
- Published by Georg Thieme Verlag KG in Laryngo-Rhino-Otologie
- Vol. 87 (6) , 392-398
Prädiktoren der nodalen Metastasierung des Larynxkarzinoms als Entscheidungshilfe bei der Neck Dissection: Literaturanalyse zur Frage zuverlässiger Parameter
Hintergrund: Bei fortgeschrittenen Plattenepithelkarzinomen des Larynx sind lokalisationsabhängig in bis zu 60 % histologisch keine Lymphknotenmetastasen nachweisbar (pN0). Andererseits enthalten über 30 % der klinisch tumorfreien Lymphknoten (cN0) okkulte Metastasen. Der Umfang der Neck Dissection (ND) ist nach den Leitlinien der Deutschen HNO-Gesellschaft abhängig vom klinischen Tumor- und Lymphknotenstadium. Bei geplanter adjuvanter Radiochemotherapie kann im Stadium cN0 auf die ND verzichtet werden. Zur besseren Planung des Umfangs der ND im Stadium cN0 stellt sich die Frage nach prädiktiven Parametern für das Risiko der Metastasierung, die an einer präoperativen Tumorbiopsie bestimmbar sind.Methode: In der vorliegenden Arbeit wurden 455 Publikationen zu folgenden Parametern analysiert: Tumorstadium, Grading, peritumoröse Entzündung, Lymphgefäßinvasion, Angioneogenese, Tumorproliferation, Überexpression von Cyclin D1 und p53, Inhibitoren der Cyclin-abhängigen Kinasen, Wachstumsfaktoren, Apoptoseindex, Zelladhäsion, nm23, Metalloproteinasen, DNA/Ploidiegrad und Tumorgenetik.Ergebnisse: In der Auswertung waren keine Parameter mit hinreichend sicherem prädiktiven Wert identifizierbar.Schlussfolgerungen: Somit bietet auch eine erweiterte Untersuchung präoperativer Biopsien keine zuverlässige Hilfe bei der Entscheidung für oder gegen eine Neck Dissection im Stadium cN0 (außerhalb von T1). Background: A subset of advanced laryngeal squamous cell carcinomas (SCC) does not metastasize in regional lymph nodes (pN0). However, more than 30 % of tumors without signs of metastasizing in the clinical examination (cN0) show occult metastases. The guidelines of the German ENT-Society intend the extent of neck dissection (ND) depending on clinical stage of tumor and lymph nodes. If laryngeal surgery is followed by an adjuvant radiation/chemotherapy, ND is not always necessary. Histomorphological, immunohistochemical, or molecular parameters with predictive value for nodal metastasizing could support the planning for ND, especially in patients with cN0.Methods: Within the last 20 years there were many publications concerning this problem. Herein, we analyzed the results of 455 publications. We have chosen studies regarding the predictive value of tumor stage, grading, peritumorous inflammation, invasion of lymphatic vessels, angioneogenesis, proliferation, overexpression of p53 or cyclin D1, inhibitors of cyclin-dependend kinases, growth factors, apoptosis, cell-adhesion, nm23, metalloproteinases, DNA/ploidy as well as tumor genetics.Results: All examined parameters did not allow a failsafe prediction of the risk for nodal metastasizing.Conclusions: Up to now, reliable predictors do not exist. The investigation of above mentioned parameters in pre-operative tumor biopsies is not helpful for the planning of ND in the stage cN0 (out of T1).
- 23 August 2007
- Published by Georg Thieme Verlag KG in Laryngo-Rhino-Otologie
- Vol. 87 (6) , 392-398
Prädiktoren der nodalen Metastasierung des Larynxkarzinoms als Entscheidungshilfe bei der Neck Dissection: Literaturanalyse zur Frage zuverlässiger Parameter
Hintergrund: Bei fortgeschrittenen Plattenepithelkarzinomen des Larynx sind lokalisationsabhängig in bis zu 60 % histologisch keine Lymphknotenmetastasen nachweisbar (pN0). Andererseits enthalten über 30 % der klinisch tumorfreien Lymphknoten (cN0) okkulte Metastasen. Der Umfang der Neck Dissection (ND) ist nach den Leitlinien der Deutschen HNO-Gesellschaft abhängig vom klinischen Tumor- und Lymphknotenstadium. Bei geplanter adjuvanter Radiochemotherapie kann im Stadium cN0 auf die ND verzichtet werden. Zur besseren Planung des Umfangs der ND im Stadium cN0 stellt sich die Frage nach prädiktiven Parametern für das Risiko der Metastasierung, die an einer präoperativen Tumorbiopsie bestimmbar sind.Methode: In der vorliegenden Arbeit wurden 455 Publikationen zu folgenden Parametern analysiert: Tumorstadium, Grading, peritumoröse Entzündung, Lymphgefäßinvasion, Angioneogenese, Tumorproliferation, Überexpression von Cyclin D1 und p53, Inhibitoren der Cyclin-abhängigen Kinasen, Wachstumsfaktoren, Apoptoseindex, Zelladhäsion, nm23, Metalloproteinasen, DNA/Ploidiegrad und Tumorgenetik.Ergebnisse: In der Auswertung waren keine Parameter mit hinreichend sicherem prädiktiven Wert identifizierbar.Schlussfolgerungen: Somit bietet auch eine erweiterte Untersuchung präoperativer Biopsien keine zuverlässige Hilfe bei der Entscheidung für oder gegen eine Neck Dissection im Stadium cN0 (außerhalb von T1). Background: A subset of advanced laryngeal squamous cell carcinomas (SCC) does not metastasize in regional lymph nodes (pN0). However, more than 30 % of tumors without signs of metastasizing in the clinical examination (cN0) show occult metastases. The guidelines of the German ENT-Society intend the extent of neck dissection (ND) depending on clinical stage of tumor and lymph nodes. If laryngeal surgery is followed by an adjuvant radiation/chemotherapy, ND is not always necessary. Histomorphological, immunohistochemical, or molecular parameters with predictive value for nodal metastasizing could support the planning for ND, especially in patients with cN0.Methods: Within the last 20 years there were many publications concerning this problem. Herein, we analyzed the results of 455 publications. We have chosen studies regarding the predictive value of tumor stage, grading, peritumorous inflammation, invasion of lymphatic vessels, angioneogenesis, proliferation, overexpression of p53 or cyclin D1, inhibitors of cyclin-dependend kinases, growth factors, apoptosis, cell-adhesion, nm23, metalloproteinases, DNA/ploidy as well as tumor genetics.Results: All examined parameters did not allow a failsafe prediction of the risk for nodal metastasizing.Conclusions: Up to now, reliable predictors do not exist. The investigation of above mentioned parameters in pre-operative tumor biopsies is not helpful for the planning of ND in the stage cN0 (out of T1).
- 18 July 2007
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 264 (12) , 1431-1436
Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas
Tumorigenesis involves energy production by aerobic glycolysis (“Warburg effect”) in malignant tumors. One of the key enzymes is transketolase. Transketolase, transketolase-like-1 (TKTL1), and transketolase-like-2 are known. Antibodies against TKTL1 exist for immunohistochemical investigations. This study investigated the influence of TKTL1 on survival and metastasizing in 40 laryngeal squamous cell carcinomas (SCCs, T2–T4, 27 metastasized). Staining was assessed by an immunoreactive score (IRS) with values from 0 to 12 in primaries and their nodal metastases. The highest IRS was 8. Normal epithelium did not show an expression. Three SCCs were negative. Advanced SCCs had a higher IRS than lower stages. An IRS > 4 was associated with a shorter disease specific survival, independent on the tumor stage in the multivariate analysis. Significant differences between metastasized and non-metastasized SCCs were absent, but poorly differentiated SCCs had a higher IRS in their metastases than moderate differentiated SCCs. TKTL1 overexpression is associated with a more aggressive behavior and shorter survival of laryngeal SCCs. These observations could lead to additional therapeutic options targeting a blocking of the enzyme activity.
- 18 July 2007
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 264 (12) , 1431-1436
Overexpression of transketolase TKTL1 is associated with shorter survival in laryngeal squamous cell carcinomas
Tumorigenesis involves energy production by aerobic glycolysis (“Warburg effect”) in malignant tumors. One of the key enzymes is transketolase. Transketolase, transketolase-like-1 (TKTL1), and transketolase-like-2 are known. Antibodies against TKTL1 exist for immunohistochemical investigations. This study investigated the influence of TKTL1 on survival and metastasizing in 40 laryngeal squamous cell carcinomas (SCCs, T2–T4, 27 metastasized). Staining was assessed by an immunoreactive score (IRS) with values from 0 to 12 in primaries and their nodal metastases. The highest IRS was 8. Normal epithelium did not show an expression. Three SCCs were negative. Advanced SCCs had a higher IRS than lower stages. An IRS > 4 was associated with a shorter disease specific survival, independent on the tumor stage in the multivariate analysis. Significant differences between metastasized and non-metastasized SCCs were absent, but poorly differentiated SCCs had a higher IRS in their metastases than moderate differentiated SCCs. TKTL1 overexpression is associated with a more aggressive behavior and shorter survival of laryngeal SCCs. These observations could lead to additional therapeutic options targeting a blocking of the enzyme activity.